Open AccessTRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
Author(s) -
Deepa Joshi,
Prashant Gj,
Shohini Ghosh,
Anookh Mohanan,
Shashank Joshi,
Viswanathan Mohan,
Subhankar Chowdhury,
Chaitanya Dutt,
Nikhil Tandon
Publication year - 2022
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s330515
Subject(s) - medicine , tolerability , blood pressure , glycated hemoglobin , dyslipidemia , placebo , insulin resistance , triglyceride , endocrinology , body mass index , insulin , type 2 diabetes , apolipoprotein b , diabetes mellitus , gastroenterology , adverse effect , cholesterol , alternative medicine , pathology